(1)
Efficacy of Difelikefalin in Subjects With Moderate-to-Severe Chronic Kidney Disease–Associated Pruritus: Pooled Subgroup Analysis of KALM-1 and KALM-2. J of Skin 2021, 5 (6), s77. https://doi.org/10.25251/skin.5.supp.77.